Written question asked by Lady Hermon (Ulster Unionist Party) on Wednesday, 2 March 2005, in the House of Commons. It was due for an answer on Tuesday, 8 March 2005. It was answered by Baroness Smith of Basildon (Labour) on Tuesday, 8 March 2005 on behalf of the Northern Ireland Office.
Northern Ireland Office
- Question
- To ask the Secretary of State for Northern Ireland, what discussions he has had with the Secretary of State for Health on the withdrawal from the NHS in Northern Ireland of certain Alzheimer's drugs following the recent recommendation by the National Institute for Clinical Excellence.
- Answer
-
Lady Hermon: To ask the Secretary of State for Northern Ireland what discussions he has had with the Secretary of State for Health on the withdrawal from the NHS in Northern Ireland of certain Alzheimer's drugs following the recent recommendation by the National Institute for Clinical Excellence. [220462] Angela Smith: I have had no discussions regarding the withdrawal of any drugs used in the treatment of Alzheimer's disease. Drugs in the generic categories Donepezil, Galantamine, Memantine and Rivastigmine remain available on Health Service prescription in Northern Ireland.
Secondary information
- Type
- Written question
- Reference
- 431 c1651W;431 c1647W; 220462
- Session
- 2004-05
- Subjects
- Alzheimer's disease Drugs NHS Medical treatments Northern Ireland Prescription drugs National Institute for Clinical Excellence
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2022-06-07 14:24:44 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1027149
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1027149
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1027149